Together, these data show that, consistent with its role in development, Bmp7 promotes the progression of triple‐negative breast cancer, and that targeting Bmp7, as a part of the interaction loop, is an effective strategy in treating this cancer subtype. The gene discussed is BMP7; the disease is cancer.